Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ethylisothiourea. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylisothiourea SCHEMBL160501 | 0.97 | — | — | |
| Ethylisothiourea SCHEMBL6837679 | 0.94 | — | — | |
| Ethylisothiourea SCHEMBL18169 | 0.94 | — | — | |
| Ethylisothiourea SCHEMBL16322930 | 0.91 | — | — | |
| Ethylisothiourea SCHEMBL7418298 | 0.91 | — | — | |
| Ethylisothiourea SCHEMBL2787239 | 0.84 | NOS1 (0.75) | — | |
| Ethylisothiourea SCHEMBL31563742 | 0.84 | NOS1 (0.75) | — | |
| Ethylisothiourea SCHEMBL4409267 | 0.84 | CYP2C19 (0.75) | — | |
| Ethylisothiourea SCHEMBL11693925 | 0.78 | NOS1 (0.65) | — | |
| Hydrochloric Acid SCHEMBL31317493 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1357952-B1 | METHOD FOR COATING MEDICAL DEVICE SURFACES | MEDTRONIC INC (US) | 2010-09-01 | — | — | EP | claimed |
| US-20060193968-A1 | Method for attachment of biomolecules to medical device surfaces | MEDTRONIC, INC. | 2006-08-31 | — | — | US | claimed |
| US-20060099326-A1 | Method for attachment of biomolecules to medical device surfaces | MEDTRONIC, INC. | 2006-05-11 | — | — | US | claimed |
| EP-1357952-A2 | METHOD FOR COATING MEDICAL DEVICE SURFACES | Medtronic, Inc. (US) | 2003-11-05 | — | — | EP | claimed |
| US-6617142-B2 | Method for attachment of biomolecules to medical device surfaces | MEDTRONIC, INC. | 2003-09-09 | — | — | US | claimed |
| US-20020120333-A1 | Method for coating medical device surfaces | KEOGH JAMES R (US) | 2002-08-29 | — | — | US | claimed |
| WO-2002060505-A2 | METHOD FOR COATING MEDICAL DEVICE SURFACES | MEDTRONIC, INC. (US) | 2002-08-08 | — | — | WO | claimed |
| US-20020001834-A1 | METHOD FOR ATTACHMENT OF BIOMOLECULES TO MEDICAL DEVICE SURFACES | MEDTRONIC, INC. | 2002-01-03 | — | — | US | claimed |
| US-6033719-A | Method for covalent attachment of biomolecules to surfaces of medical devices | MEDTRONIC, INC. (US) | 2000-03-07 | — | — | US | claimed |
| US-5928916-A | Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces | MEDTRONIC, INC. (US) | 1999-07-27 | — | — | US | claimed |
| US-5925552-A | Method for attachment of biomolecules to medical devices surfaces | MEDTRONIC, INC. (US) | 1999-07-20 | — | — | US | claimed |
| US-12517133-B2 | Macromolecule analysis employing nucleic acid encoding | DF PEPTIDE ACQUISITION LLC | 2026-01-06 | — | — | US | disclosed |
| US-12467049-B2 | Methods and kits using nucleic acid encoding and/or label | DF PEPTIDE ACQUISITION LLC | 2025-11-11 | — | — | US | disclosed |
| US-12320813-B2 | Macromolecule analysis employing nucleic acid encoding | Encodia, Inc. (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250164499-A1 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | DF PEPTIDE ACQUISITION LLC | 2025-05-22 | — | — | US | disclosed |
| US-5925552-A | Method for attachment of biomolecules to medical devices surfaces | MEDTRONIC, INC. (US) | 1999-07-20 | — | — | US | disclosed |
| US-4748162-A | 6-substituted-2-carbaminidoyl-pen-2-em-3-carboxylic acids | MERCK & CO., INC. (US) | 1988-05-31 | — | — | US | disclosed |
| EP-0087792-A1 | 6-Substituted-2-carbamimidoyl-pen-2-em-3-carboxylic acids, process for preparing them and antibiotic compositions comprising them | MERCK & CO. INC. (US) | 1983-09-07 | — | — | EP | disclosed |
| US-4026936-A | Anthelmintic pyridine and thiazole substituted benzimidazole carbamates | HOFFMANN-LA ROCHE INC. (US) | 1977-05-31 | — | — | US | disclosed |
| US-3957785-A | ADRENOLYTICS, NONTOXIC, HYPOTENSIVE AGENTS, ANALGESICS | SOCIETA' FARMACEUTICI ITALIA S.P.A. (IT) | 1976-05-18 | — | — | US | disclosed |